BionTech

Photo: Collected.
Coronavirus chronicle

Pfizer, BioNTech vaccine neutralises Omicron with three shots

Blood obtained from people that had their third booster shot a month ago neutralised the Omicron variant about as effectively as blood after two doses fought off the original virus first identified...

The company said that it was interested in working exclusively with the government. Photo: Reuters
Coronavirus chronicle

Pfizer, BioNTech, Moderna making $1,000 profit every second: Analysis

FILE PHOTO: The headquarters of biopharmaceutical company BioNTech are seen in Mainz, Germany July 31, 2018. REUTERS/Ralph Orlowski
Coronavirus chronicle

BioNTech sees up to 17 bln eur in vaccine revenue this year

A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
Coronavirus chronicle

US FDA advisers back Pfizer/BioNTech Covid-19 vaccine for children

Syringes are seen in front of a displayed Biontech logo in this illustration taken November 10, 2020. REUTERS/Dado Ruvic/Illustration
World+Biz

Civil society calls on candidates for German chancellor to waive intellectual property rules on Covid vaccines

FILE PHOTO: The headquarters of biopharmaceutical company BioNTech are seen in Mainz, Germany July 31, 2018. REUTERS/Ralph Orlowski
Global Economy

BioNTech alone could lift German economy by 0.5% this year - economist

Syringes are seen in front of a displayed Biontech logo in this illustration taken November 10, 2020. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

BioNTech to build mRNA vaccine manufacturing site in Singapore

Syringes are seen in front of a displayed Biontech logo in this illustration taken November 10, 2020. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

BioNTech expects vaccine trial results for babies by September

Sierk Poetting, CFO of German biotech firm BioNTech, is interviewed by journalists in Marburg, Germany September 17, 2020. REUTERS/Fabian Bimmer
Coronavirus chronicle

BioNTech sees scope for further capacity expansion: CFO

Hong Kong says initial investigation of BioNTech vaccines shows no 'obvious systemic factors'
Coronavirus chronicle

Hong Kong says initial investigation of BioNTech vaccines shows no 'obvious systemic factors'

FILE PHOTO: The headquarters of biopharmaceutical company BioNTech are seen in Mainz, Germany July 31, 2018. REUTERS/Ralph Orlowski
Coronavirus chronicle

Taiwan says BioNTech vaccine deal on hold, cites potential Chinese pressure

"Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," said Ugur Sahin, chief executive of the company.  Photo: Collected
Coronavirus chronicle

BioNTech says can make mutation-beating coronavirus vaccine in six weeks

Photo: Collected.
Coronavirus chronicle

BioNTech says 140,000 vaccinated in Britain so far